Le Lézard
Classified in: Mining industry, Science and technology

J?b Industrial Services Announces Rebrand to J?b EPC Company


After 19 years of delivering high-quality services to clients within the refining, petrochemical, midstream, agricultural, mining and industrial sectors, J?b Industrial Services is now J?b EPC Company.

SALT LAKE CITY, May 7, 2024 /PRNewswire-PRWeb/ -- J?b Industrial Services, a national engineering, procurement and construction (EPC) company, has officially rebranded to J?b EPC Company (JEPCO).

"This new name helps place our core offering at the heart of who we are: a leading provider of comprehensive EPC services." - Jason Job, JEPCO Founder

Founded in 2005, J?b EPC Company provides EPC, standalone engineering and specialty chemical optimization services for clients across North America. According to founder Jason Job, the rebrand's primary purpose is to reflect J?b's service offerings more accurately.

 

"For the past two decades, J?b Industrial Services has been a valuable partner to heavy industry, refining and petrochemical markets across the United States," Job said. "We've built a reputation as a firm that provides top-tier engineering services, but that's not all we do. This new name helps place our core offering at the heart of who we are: a leading provider of comprehensive EPC services."

Although the company's name has slightly changed, one aspect remains: J?b. During planning sessions, Vice President of Operations Randy Nelson and other members of the J?b team emphasized the importance of combining the old with the new within the rebrand.

"People know the name 'J?b' throughout the industry, and we knew we wanted to keep that as part of our identity," Randy said. "This way, J?b EPC Company embraces the legacy we've created while looking to our future as a top-tier EPC provider."

The company's website, social media channels and other materials will be updated to reflect the new name and brand identity. Steve Wendel, J?b EPC Company's president and chief executive officer, is optimistic about what the future holds under the new brand.

"J?b EPC Company is excited to embark on this new chapter of our journey," said Steve. "With this rebrand, we're reaffirming our commitment to providing exceptional EPC services to our clients while embracing our heritage as a trusted name in the industry. Our goal remains unchanged: to deliver innovative solutions that exceed expectations and drive success for our clients."

About J?b EPC Company

Since 2005, J?b EPC Company has delivered top-notch EPC, standalone engineering and specialty chemical optimization services for our clients within the refining, petrochemical, midstream, agricultural, mining and industrial sectors nationwide. By combining a talented team with cutting-edge technology, we're here to support you through the entirety of your project's life cycle. For more information, visit jobepc.com or J?b EPC Company on Facebook.

Media Contact

Lisa Tyree, J?b EPC Company, 1 713-202-3507, [email protected], jobepc.com

LinkedIn

SOURCE J?b EPC Company


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: